Rilonacept April 12, 2017 Rilonacept Trade Name Arcalyst Orphan Indication CIAS1-Associated Periodic Syndromes USA Market Approval USA USA Designation Date 2004-12-20 00:00:00 Sponsor Regeneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591
